Business

Imaging Biometrics Installs IB Nimble™ For MCW

Imaging Biometrics Installs IB Nimble™ For MCW.

articleImaging Biometrics LimitedJuly 19, 20235/company/imaging-biometrics-limited/news/imaging-biometrics-installs-ib-nimbletm-for-mcw
Imaging Biometrics Installs IB Nimble™ For MCW

About this update from Imaging Biometrics Limited

[{"type":"text","content":"\n\n19 July 2023\nIQ-AI Ltd\n(\"IQ-AI\" or the \"Company\")\n \nImaging Biometrics Installs IB Nimble™ For MCW Bone Mets Treatment\n  \nImaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCQB: IQAIF), today announced that its handheld application, IB Nimble, has been adopted by Orthopedic Department of the Medical College of Wisconsin for use in their treatment of bone metastases. The handheld app provides real-time collaboration amongst multi-disciplinary teams securely and asynchronously.\n \nDesigned initially by Dr. Joseph Bovi, MD, Professor of Radiation Oncology and Neurosurgery at MCW, for brain metastases, IB Nimble's base functionality has been enhanced to accommodate any disease or pathology that requires multi-disciplinary input. The clinical benefit of providing optimized treatments faster to patients with brain metastases is now being afforded to patients with bone mets.\n \n\"This marks the first installation for use in diseases sites other than brain metastases and demonstrates that IB Nimble is ready for widespread deployment,\" said Josh McComack, IB's Director of Software Engineering.\n \n--ENDS-\n \nThe Directors of the Company accept responsibility for the contents of this announcement.\n \nFor further information, please contact:\n \n\n\n\nIQ-AI Ltd\nTrevor Brown/Vinod Kaushal/Brett Skelly/Michael Schmainda\nTel: 020 7469 0930\n\n\n\n\nPeterhouse Capital Limited (Financial Adviser and Broker)\nLucy Williams/Heena Karani\nTel: 020 7220 9797\n\n\n\n \nAbout Imaging Biometrics® LLC:  IB is a wholly-owned subsidiary of IQ-AI Limited, (LON: IQAI) (OTCQB: IQAIF), and focuses on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com. Follow IB on Twitter, @IQAI_IB.\n\n","length":3907,"tagName":"div"}]

More updates from Imaging Biometrics Limited